These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18411939)

  • 1. Risk modelling for vaccination: a risk assessment perspective.
    Wooldridge M
    Dev Biol (Basel); 2007; 130():87-97. PubMed ID: 18411939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based immunization in horses.
    Barquero N; Gilkerson JR; Newton JR
    Vet Clin North Am Equine Pract; 2007 Aug; 23(2):481-508. PubMed ID: 17616324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination benefits, risks and safety: the need for a complete picture.
    Pless R
    Bull World Health Organ; 2000; 78(2):219-21. PubMed ID: 10743290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A geographical spread of vaccine-resistance in avian influenza epidemics.
    Iwami S; Takeuchi Y; Liu X; Nakaoka S
    J Theor Biol; 2009 Jul; 259(2):219-28. PubMed ID: 19361532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safe use of vaccines and vaccine compliance with food safety requirements.
    Grein K; Papadopoulos O; Tollis M
    Rev Sci Tech; 2007 Aug; 26(2):339-50. PubMed ID: 17892156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dengue fever: from disease to vaccination].
    Teyssou R
    Med Trop (Mars); 2009 Aug; 69(4):333-4. PubMed ID: 19725380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
    Souayah N; Nasar A; Suri MF; Qureshi AI
    J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms underlying adverse reactions to vaccines.
    Siegrist CA
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S46-50. PubMed ID: 17559869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of risk assessments on Campylobacter in broiler meat.
    Nauta M; Hill A; Rosenquist H; Brynestad S; Fetsch A; van der Logt P; Fazil A; Christensen B; Katsma E; Borck B; Havelaar A
    Int J Food Microbiol; 2009 Feb; 129(2):107-23. PubMed ID: 19136176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current developments in avian influenza vaccines, including safety of vaccinated birds as food.
    Swayne DE; Suarez DL
    Dev Biol (Basel); 2007; 130():123-33. PubMed ID: 18411943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose response effects of avian influenza (H7N7) vaccination of chickens: serology, clinical protection and reduction of virus excretion.
    Maas R; Tacken M; van Zoelen D; Oei H
    Vaccine; 2009 Jun; 27(27):3592-7. PubMed ID: 19464539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative risk assessment of pesticide residues in food.
    Boobis AR; Ossendorp BC; Banasiak U; Hamey PY; Sebestyen I; Moretto A
    Toxicol Lett; 2008 Aug; 180(2):137-50. PubMed ID: 18585444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine therapy in patients with renal cell carcinoma.
    Van Poppel H; Joniau S; Van Gool SW
    Eur Urol; 2009 Jun; 55(6):1333-42. PubMed ID: 19201522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the incorporation of chemical-specific information in risk assessment.
    Clewell HJ; Andersen ME; Blaauboer BJ
    Toxicol Lett; 2008 Aug; 180(2):100-9. PubMed ID: 18588959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which pharmacovigilance for vaccines?
    Le Louët H; Loupi E; Haramburu F;
    Therapie; 2007; 62(3):241-7. PubMed ID: 17803893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OIE standards for vaccines and future trends.
    Edwards S
    Rev Sci Tech; 2007 Aug; 26(2):373-8. PubMed ID: 17892158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Death and serious illness following influenza vaccination: a multidisciplinary investigation.
    Rue-Cover A; Iskander J; Lyn S; Burwen DR; Gargiullo P; Shadomy S; Blostein J; Bridges CB; Haber P; Satzger RD; Ball R; Seward JF
    Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):504-11. PubMed ID: 19373848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.